360 related articles for article (PubMed ID: 25802102)
1. Marrow adipocyte-derived CXCL1 and CXCL2 contribute to osteolysis in metastatic prostate cancer.
Hardaway AL; Herroon MK; Rajagurubandara E; Podgorski I
Clin Exp Metastasis; 2015 Apr; 32(4):353-68. PubMed ID: 25802102
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow fat: linking adipocyte-induced inflammation with skeletal metastases.
Hardaway AL; Herroon MK; Rajagurubandara E; Podgorski I
Cancer Metastasis Rev; 2014 Sep; 33(2-3):527-43. PubMed ID: 24398857
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil recruitment by chemokines Cxcl1/KC and Cxcl2/MIP2: Role of Cxcr2 activation and glycosaminoglycan interactions.
Sawant KV; Sepuru KM; Lowry E; Penaranda B; Frevert CW; Garofalo RP; Rajarathnam K
J Leukoc Biol; 2021 Apr; 109(4):777-791. PubMed ID: 32881070
[TBL] [Abstract][Full Text] [Related]
4. Chemokine (C-X-C motif) ligand 1 and CXCL2 produced by tumor promote the generation of monocytic myeloid-derived suppressor cells.
Shi H; Han X; Sun Y; Shang C; Wei M; Ba X; Zeng X
Cancer Sci; 2018 Dec; 109(12):3826-3839. PubMed ID: 30259595
[TBL] [Abstract][Full Text] [Related]
5. Critical role of MKP-1 in lipopolysaccharide-induced osteoclast formation through CXCL1 and CXCL2.
Valerio MS; Herbert BA; Basilakos DS; Browne C; Yu H; Kirkwood KL
Cytokine; 2015 Jan; 71(1):71-80. PubMed ID: 25261746
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow adipocytes promote the Warburg phenotype in metastatic prostate tumors via HIF-1α activation.
Diedrich JD; Rajagurubandara E; Herroon MK; Mahapatra G; Hüttemann M; Podgorski I
Oncotarget; 2016 Oct; 7(40):64854-64877. PubMed ID: 27588494
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow adipocytes enhance osteolytic bone destruction by activating 1q21.3(S100A7/8/9-IL6R)-TLR4 pathway in lung cancer.
Luo G; Tang M; Zhao Q; Lu L; Xie Y; Li Y; Liu C; Tian L; Chen X; Yu X
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2241-2253. PubMed ID: 32494918
[TBL] [Abstract][Full Text] [Related]
8. The Clinicopathological Significance of the CXCR2 Ligands, CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, CXCL7, and CXCL8 in Gastric Cancer.
Yamamoto Y; Kuroda K; Sera T; Sugimoto A; Kushiyama S; Nishimura S; Togano S; Okuno T; Yoshii M; Tamura T; Toyokawa T; Tanaka H; Muguruma K; Ohira M; Yashiro M
Anticancer Res; 2019 Dec; 39(12):6645-6652. PubMed ID: 31810929
[TBL] [Abstract][Full Text] [Related]
9. NFκB-mediated CXCL1 production in spinal cord astrocytes contributes to the maintenance of bone cancer pain in mice.
Xu J; Zhu MD; Zhang X; Tian H; Zhang JH; Wu XB; Gao YJ
J Neuroinflammation; 2014 Mar; 11():38. PubMed ID: 24580964
[TBL] [Abstract][Full Text] [Related]
10. CXCL1-Chemokine (C-X-C Motif) Receptor 2 Signaling Stimulates the Recruitment of Bone Marrow-Derived Mesenchymal Cells into Diffuse-Type Gastric Cancer Stroma.
Kasashima H; Yashiro M; Nakamae H; Kitayama K; Masuda G; Kinoshita H; Fukuoka T; Hasegawa T; Nakane T; Hino M; Hirakawa K; Ohira M
Am J Pathol; 2016 Nov; 186(11):3028-3039. PubMed ID: 27742059
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow adipocytes promote tumor growth in bone via FABP4-dependent mechanisms.
Herroon MK; Rajagurubandara E; Hardaway AL; Powell K; Turchick A; Feldmann D; Podgorski I
Oncotarget; 2013 Nov; 4(11):2108-23. PubMed ID: 24240026
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow-derived cathepsin K cleaves SPARC in bone metastasis.
Podgorski I; Linebaugh BE; Koblinski JE; Rudy DL; Herroon MK; Olive MB; Sloane BF
Am J Pathol; 2009 Sep; 175(3):1255-69. PubMed ID: 19700761
[TBL] [Abstract][Full Text] [Related]
13. CXCL2 synthesized by oral squamous cell carcinoma is involved in cancer-associated bone destruction.
Oue E; Lee JW; Sakamoto K; Iimura T; Aoki K; Kayamori K; Michi Y; Yamashiro M; Harada K; Amagasa T; Yamaguchi A
Biochem Biophys Res Commun; 2012 Aug; 424(3):456-61. PubMed ID: 22771802
[TBL] [Abstract][Full Text] [Related]
14. The Chemokine Receptor CCR3 Is Potentially Involved in the Homing of Prostate Cancer Cells to Bone: Implication of Bone-Marrow Adipocytes.
Guérard A; Laurent V; Fromont G; Estève D; Gilhodes J; Bonnelye E; Le Gonidec S; Valet P; Malavaud B; Reina N; Attané C; Muller C
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671469
[TBL] [Abstract][Full Text] [Related]
15. CXCR2 and CXCR4 antagonistically regulate neutrophil trafficking from murine bone marrow.
Eash KJ; Greenbaum AM; Gopalan PK; Link DC
J Clin Invest; 2010 Jul; 120(7):2423-31. PubMed ID: 20516641
[TBL] [Abstract][Full Text] [Related]
16. Augmented osteolysis in SPARC-deficient mice with bone-residing prostate cancer.
McCabe NP; Kerr BA; Madajka M; Vasanji A; Byzova TV
Neoplasia; 2011 Jan; 13(1):31-9. PubMed ID: 21245938
[TBL] [Abstract][Full Text] [Related]
17. Caprylic acid (C8:0) promotes bone metastasis of prostate cancer by dysregulated adipo-osteogenic balance in bone marrow.
Wang C; Wang J; Chen K; Pang H; Li X; Zhu J; Ma Y; Qiu T; Li W; Xie J; Zhang J
Cancer Sci; 2020 Oct; 111(10):3600-3612. PubMed ID: 32770813
[TBL] [Abstract][Full Text] [Related]
18. CXCR2-mediated tumor-associated neutrophil recruitment is regulated by IFN-β.
Jablonska J; Wu CF; Andzinski L; Leschner S; Weiss S
Int J Cancer; 2014 Mar; 134(6):1346-58. PubMed ID: 24154944
[TBL] [Abstract][Full Text] [Related]
19. CXCL2 mediates lipopolysaccharide-induced osteoclastogenesis in RANKL-primed precursors.
Ha J; Lee Y; Kim HH
Cytokine; 2011 Jul; 55(1):48-55. PubMed ID: 21507677
[TBL] [Abstract][Full Text] [Related]
20. Receptor activator of nuclear factor kappaB ligand (RANKL) is a key molecule of osteoclast formation for bone metastasis in a newly developed model of human neuroblastoma.
Michigami T; Ihara-Watanabe M; Yamazaki M; Ozono K
Cancer Res; 2001 Feb; 61(4):1637-44. PubMed ID: 11245477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
